Alibaba raised $21.8 billion in its IPO on Friday, making it the world's largest IPO ever. At $94, Alibaba commands a diluted market value of $242 billion; it is now the 10th-largest US-listed company, just behind Walmart. With one deal, the total capital...read more
ProQR Therapeutics, a preclinical Dutch biotech that is developing an mRNA repair therapy for cystic fibrosis, raised $98 million by offering 7.5 million shares (upsized from 6.3 million) at $13, the high end of the $11-$13 range. Insiders, including Sofinnova...read more
The IPO market has returned in full force, beginning with the 117% first-day pop of ReWalk Robotics (RWLK) on Friday, the year's fifth IPO to double on the first day (since Castlight Health in March) and the only IPO to do so after pricing below the range...read more
ProQR Therapeutics, a Dutch biotech developing mRNA treatments for cystic fibrosis, announced terms for its IPO on Monday. The Leiden, Netherlands-based company plans to raise $75 million by offering 6.3 million shares at a price range of $11 to $13. At the...read more
US IPO Pricing Recap: Alibaba pops 38%, represents one third of 2014 IPO market proceeds
Alibaba raised $21.8 billion in its IPO on Friday, making it the world's largest IPO ever. At $94, Alibaba commands a diluted market value of $242 billion; it is now the 10th-largest US-listed company, just behind Walmart. With one deal, the total capital...read more
ProQR Therapeutics prices upsized IPO at $13, the high end of the range
ProQR Therapeutics, a preclinical Dutch biotech that is developing an mRNA repair therapy for cystic fibrosis, raised $98 million by offering 7.5 million shares (upsized from 6.3 million) at $13, the high end of the $11-$13 range. Insiders, including Sofinnova...read more
Alibaba and 6 health care IPOs planned for the week of September 15
The IPO market has returned in full force, beginning with the 117% first-day pop of ReWalk Robotics (RWLK) on Friday, the year's fifth IPO to double on the first day (since Castlight Health in March) and the only IPO to do so after pricing below the range...read more
ProQR Therapeutics sets terms for $75 million IPO
ProQR Therapeutics, a Dutch biotech developing mRNA treatments for cystic fibrosis, announced terms for its IPO on Monday. The Leiden, Netherlands-based company plans to raise $75 million by offering 6.3 million shares at a price range of $11 to $13. At the...read more